Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Raventos

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibodyG L DeNardo, S J DeNardo, K R Lamborn, et al.
Journal of Visceral Surgery|May 14, 2013
Is port-site resection necessary in the surgical management of gallbladder cancer?D Fuks, J-M Regimbeau, P Pessaux, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibodyG L DeNardo, S J DeNardo, K R Lamborn, et al.
Journal of Visceral Surgery|May 14, 2013
Is port-site resection necessary in the surgical management of gallbladder cancer?D Fuks, J-M Regimbeau, P Pessaux, et al.
Pageof 4